Prostate Cancer

This course compiles the most recent clinical guidelines edited by the EAU on Prostate Cancer (PCa). The course is divided into 3 learning modules. Each learning module consists of multiple-choice questions that you can answer by navigating to the corresponding chapter of the PCa guideline. The questions are offered for self-assessment of your knowledge of the EAU Guidelines on Prostate Cancer.

Prostate cancer (PCa) is estimated as the 4th most common cancer in Europe, and is the most frequent cancer and 3rd predicted cause of all cancer deaths among males. Incidence and disease stage distribution patterns follow biological, genetic, and/or lifestyle factors, but are also influenced by (inter)national organisations' recommendations on the use of PSA testing.

Prostate cancer (PCa) is estimated as the 4th most common cancer in Europe, and is the most frequent cancer and 3rd predicted cause of all cancer deaths among males. Review the EAU Guidelines on diagnosis, imaging and clinical staging for establishing a best-practice treatment path.

In this first edition of two updates, Professor Nicolas Mottet, the chair of the EAU Guidelines panel for prostate cancer, highlights the work of the panel.

In this second edition of two updates, Professor Nicolas Mottet discusses the most important changes and new recommendations in the 2022 EAU Guidelines for prostate cancer, with a focus on treatment approaches.

This Cheat Sheet is a joint effort by the EAU-EANM-ESTRO-ESUR-ISUP-SIOG to review the guidelines on the treatment of Prostate Cancer.